Table 3.

Associations of multiple sclerosis, ulcerative colitis, Kawasaki disease with COVID-19 vaccination in MR analyses.

Outcome	SNP (n)	Method	OR	p_value	95%(CI)
MS	51	MR Egger	4.08	0.01	1.59–10.52
MS	51	Weighted median	1.75	0.02	1.08–2.83
MS	51	Inverse variance weighted	1.53	0.02	1.06–2.20
MS	51	Simple mode	2.22	0.16	0.75–6.54
MS	51	Weighted mode	2.09	0.18	0.73–5.98
UC	28	MR Egger	1.00	0.52	0.99–1.01
UC	28	Weighted median	1.00	0.30	1.00–1.00
UC	28	Inverse variance weighted	1.00	0.04	1.00–1.00
UC	28	Simple mode	1.00	0.47	1.00–1.01
UC	28	Weighted mode	1.00	0.50	1.00–1.00
Kawasaki disease	1	Wald ratio	5982.14	0.04	1.43–25033402.50

MS, multiple sclerosis; UC, ulcerative colitis; CI, confidence interval; IVW, inverse-variance weighted; OR, odds ratio.